RV Invest
VC Fund
Ravensburg, Germany
RV Invest is a VC fund in Ravensburg focused on Biotechnology and Health Care. RV Invest early and stand alongside founders and researchers to bring outstanding ideas to the market.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries RV Invest invests in
Stages RV Invest invests in
Countries RV Invest invests in
Investment Focus
Industry
- Biotechnology 5 (83%)
- Health Care 3 (50%)
- Therapeutics 3 (50%)
- Medical 1 (17%)
- Oncology 1 (17%)
Stage
- Series A 3 (50%)
- Seed 2 (33%)
- Series B 1 (17%)
Country
- United States 2 (33%)
- Sweden 1 (17%)
- Germany 1 (17%)
- United Kingdom 1 (17%)
- The Netherlands 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Diagonal Therapeutics
|
Diagonal Therapeutics is a biotechnology startup that is pioneering a novel technique to finding and producing agonist antibodies. Diagonal Therapeutics platform combines novel computational and experimental methodologies to solve the traditional obstacles associated with agonist antibody drug development. | $125M / Series B / Jan 08, 2026 | |
Valink Therapeutics
|
Valink Therapeutics is a health care drug discovery for next-generation cancer treatments. | $11.8M / Seed / Oct 20, 2025 | |
Akribion Genomics
|
Akribion Genomics develops gene-editing tools and cancer therapies using CRISPR nuclease technology. | $8.3M / Seed / Feb 04, 2025 | |
Alesta Therapeutics
|
Alesta Therapeutics focused on translating novel targets in the chronic stress response pathways into new therapeutic approaches to treat cancer | $67M / Series A / Jan 08, 2025 | |
Arda Therapeutics
|
Arda Therapeutics is a biotechnology company taking aim at chronic diseases and aging by eliminating the pathogenic cells that drive these conditions. Their approach starts by using single-cell data to identify pathogenic cells and specific markers to target them. They then design therapies to eliminate these - and only these - cells.Arda wasfounded in 2021 in the San Francisco Bay Area, CA. | $43M / Series A / Oct 01, 2024 | |
Asgard Therapeutics
|
Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biologicalproperties of professional antigen-presenting cells. | $32.6M / Series A / Mar 14, 2024 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does RV Invest invest in?
RV Invest invests primarily in Biotechnology, Health Care and Therapeutics startups, most often at Series A and Seed stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did RV Invest last invest?
The most recent investment recorded for RV Invest closed in Jan 2026. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
